• UCLA Health
  • myUCLAhealth
  • School of Medicine
Research

Research Programs

Research
  • Back to Division of Digestive Diseases
  • About Us
    • From the Chiefs
    • Clinical Trials and Studies
    • DDW Abstracts
    • Research Council
  • Themes
    • Brain-Gut Microbiome
    • Cancer
    • Inflammatory Bowel Disease
    • Interventional Endoscopy
    • Liver Disease
    • Metabolism and Obesity
  • Centers
    • Center for Inflammatory Bowel Diseases
    • Center for Obesity and METabolic Health (COMET)
    • Center for Systems Biomedicine
    • CURE: Digestive Diseases Research Center
    • G. Oppenheimer Center for Neurobiology of Stress and Resilience
  • Labs and Programs
    • Anton Laboratory
    • Beaven Laboratory
    • Benhammou Laboratory
    • Dong Laboratory
    • Gupta Laboratory
    • Familial Mediterranean Fever Laboratory
    • Han Laboratory
    • Hemostasis Research
    • Health Services Research
    • Hepatology Research
    • Hsiao Laboratory
    • Interventional Endoscopy Research
    • Jacob Laboratory
    • Jacobs Laboratory
    • Joshi Laboratory
    • Kaunitz Laboratory
    • Koon Laboratory
    • Limketkai Laboratory
    • May Laboratory
    • Mulugeta Laboratory
    • Patel Laboratory
    • Pisegna Laboratory
    • Rozengurt Laboratory
    • Saab Laboratory
    • Sachs Laboratory
    • Sternini Laboratory
    • Tabibian Laboratory
    • Taché Laboratory
    • Videlock Laboratory
  • Training Programs
    • Fellowship Seed Grants
    • GI Fellowship Program
    • NIH T32 Training Grant
    • Specialty Training and Advanced Research (STAR) Program
  • Research Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Research Programs

Training Programs

Training Programs

Training Programs

  • Fellowship Seed Grants
    • Seed Grants 2021
    • Seed Grants 2020
    • Seed Grants 2019
    • Seed Grants 2018
    • Seed Grants 2017
    • Seed Grants 2016
    • Seed Grants 2015
  • GI Fellowship Program
  • NIH T32 Training Grant
  • Specialty Training and Advanced Research (STAR) Program
  • Fellowship Seed Grants
  • GI Fellowship Program
  • NIH T32 Training Grant
  • Specialty Training and Advanced Research (STAR) Program
  • Seed Grants 2021
  • Seed Grants 2020
  • Seed Grants 2019
  • Seed Grants 2018
  • Seed Grants 2017
  • Seed Grants 2016
  • Seed Grants 2015
  1. Home
  2. Research
  3. Training Programs
  4. Fellowship Seed Grants
  5. Seed Grants 2020

Seed Grants 2020

Share this
Ashwinee Condon MD
Training in Small Bowel Capsule Endoscopy: Establishing a Curriculum and Assessing Competency in a Fellowship Training Program
Fellow: Ashwinee S. Condon, MD
Mentor/PI: Stephen Kim, Director, Faculty Career Development in Advanced Endoscopy

The primary aim of this study is to establish an evidence-based curriculum for training in capsule endoscopy for gastroenterology fellows at the University of California Los Angeles (UCLA). The secondary aims are to develop an assessment tool to evaluate competency in CE that can be implemented by gastroenterology training programs nationwide, and to evaluate this tool prospectively by analyzing fellow competency in capsule endoscopy during three consecutive years of gastroenterology fellowship training. 

Sonya Dasharathy MD
Assessing and Improving Pneumococcal Vaccination Rates in Patients with Inflammatory Bowel Disease (IBD) at UCLA
Fellow: Sonya Dasharathy, MD
Mentors: Jenny Sauk, MD, Director of Clinical Care, UCLA Center for Inflammatory Bowel Diseases; Folasade P. May, MD, PhD, MPhil, Director, Melvin and Bren Simon GI Quality Program; Berkeley Limketkai, MD, PhD, Director of Clinical Research, UCLA Center for Inflammatory Bowel Diseases

Patients with inflammatory bowel disease (IBD) are at increased risk for pneumonia and this risk is more prominent in patients on narcotics, corticosteroids, immunosuppressive medications and PPIs. In addition, IBD patients who are hospitalized for pneumonia have increased mortality. Based on the CDC guidelines published in 2012, vaccination with both the pneumococcal polysaccharide vaccine (PPSV23) and the pneumococcal conjugate vaccine (PCV13) is advised for IBD patients who are receiving immunosuppressive treatment. Previous studies have shown low pneumococcal vaccination rates among IBD patients (9-38%), yet few have assessed which specific vaccines are recommended and administered. We therefore seek to determine the pneumococcal vaccination recommendation and administration rates among IBD patients on immunosuppressive therapy and assess the barriers to vaccination by surveying GI providers, PCPs, and patients. With this information, we hope to develop an intervention to improve pneumococcal vaccination rates among IBD patients at UCLA who are on immunosuppressive therapy.

Adrienne Lenhart MD
Neuromodulation with Percutaneous Electrical Nerve Field Stimulation for Adults with Irritable Bowel Syndrome: A Randomized, Double-Blind, Sham-Controlled Pilot
Fellow: Adrienne Lenhart, MD
Mentor/PI: Lin Chang, MD, Co-Director, UCLA G. Oppenheimer Center for Neurobiology of Stress and Resilience

Visceral hypersensitivity, autonomic nervous system dysfunction, and changes in brain-gut interactions are important concepts in the pathophysiology of irritable bowel syndrome (IBS). Despite recent advances in medical therapies for IBS, a significant subgroup of patients fails to experience satisfactory relief of abdominal pain. Given evidence of anti-inflammatory and anti-nociceptive components of vagal nerve pathways, peripheral field stimulation of the vagus nerve may help reduce visceral sensitivity in IBS patients. Percutaneous electrical nerve field stimulation (PENFS) administered via the IB-Stim device (Innovative Health Solutions, Versailles, IN, USA) has been shown to be efficacious in adolescent patients aged 11-18 years with abdominal-pain-related functional GI disorders. However, the efficacy of PENFS in adults with IBS is not unknown. Our current study is a double-blind, randomized, sham-controlled pilot study that aims to evaluate the efficacy of PENFS using the IB-Stim for the treatment of IBS symptoms in adult patients with IBS.

Sarah Park MD
VSI-IBD: A Measure of GI-Symptom Specific Anxiety in IBD
Fellow: Sarah Park, MD
Mentor/PI: Lin Chang, MD, Co-Director, UCLA G. Oppenheimer Center for Neurobiology of Stress and Resilience


Jeremy Wang MD
Determining Whether Retained Esophageal Contrast on Modified Barium Swallow Study Predicts Abnormal High-Resolution Esophageal Manometry
Fellow: Jeremy Wang, MD
Mentor/PI: Jeffrey L. Conklin, MD, Medical Director, UCLA Robert G. Kardashian Center for Esophageal Health and Director, GI Motility Program

Dysphagia is a frequently reported symptom, affecting up to 13 percent of the general population and leading to significant morbidity. Clinically, it is divided into oropharyngeal and esophageal causes to guide diagnostic evaluation. The modified barium swallow study (MBSS) is used to evaluate oropharyngeal dysphagia. The main limitation of the MBSS is the inability to assess for any significant esophageal dysfunction. At our institution, a brief fluoroscopic assessment for retained esophageal contrast is performed one minute after completion of the standard exam. A positive finding may indicate an underlying esophageal motility disorder. This study seeks to determine whether retained esophageal contrast on MBSS is associated with abnormal high-resolution esophageal manometry (HREM), classify the HREM findings according to the Chicago Classification v3.0, and hopefully develop a new protocol that incorporates an esophageal assessment into the standard MBSS exam.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth